Table 7.

Financial benefits (in €) associated with vaccination of previously non-vaccinated sows (pnonVS) for different levels of vaccination effectiveness and proportion of newly vaccinated sows.

Proportion of sows vaccinated with nVac	Vaccination effectiveness
	50%	60%	70%	80%	90%
1%	2′851′317	3′400′409	3′967′309	4′543′155	5′113′805
2%	5′702′634	6′800′818	7′934′618	9′086′310	10′227′609
3%	8′553′951	10′201′228	11′901′928	13′629′465	15′341′414
4%	11′405′267	13′601′637	15′869′237	18′172′620	20′455′219
5%	14′256′584	17′002′046	19′836′546	22′715′776	25′569′023
6%	17′107′901	20′402′455	23′803′855	27′258′931	30′682′828
7%	19′959′218	23′802′864	27′771′165	31′802′086	35′796′633
8%	22′810′535	27′203′273	31′738′474	36′345′241	40′910′437
9%	25′661′852	30′603′683	35′705′783	40′888′396	46′024′242
10%	28′513′168	34′004′092	39′673′092	45′431′551	51′138′047